The U.S. Food and Drug Administration recently approved a new oral medication for the treatment of rheumatoid arthritis that represents a new class of drugs for the disease. The drug, tofacitinib (Xeljanz), provides a new treatment option for adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to, or who are intolerant of, methotrexate, a standard therapy for the disease.

Related posts:

  1. Drug halts organ damage in inflammatory genetic disorder A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease (NOMID). This rare and debilitating genetic disorder causes persistent inflammation and ongoing tissue damage. The research was performed by scientists at the National […]...
  2. Medicare Medical Care, Rapid Development of Drug-Resistant, 2009 H1N1 Influenza Reported in Two Cases Two people with compromised immune systems who became ill with 2009 H1N1 influenza developed drug-resistant strains of virus after less than two weeks on therapy, report doctors from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Doctors who treat prolonged influenza infection should be aware that even a short course of antiviral treatment may lead to drug-resistant virus, say the authors, and clinicians should consider this possibility as they develop initial treatment strategies for their patients who have impaired immune function....
  3. HIV/AIDS Treatment Curbs Spread of HIV Among Drug Users, According to NIH Supported Study Highly active antiretroviral therapy (HAART), currently known for its therapeutic benefits against HIV, also reduced the spread of the virus among people with a history of injection drug use, according to a population-based study funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. The study was published […]...
  4. NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute […]...
  5. Replacement Medicare Card – www.ssa.gov/medicarecard REPLACEMENT MEDICARE CARD...
  6. How to get a new medicare replacement card Here is some helpful information we found on how to get a replacement medicare card...
  7. Medicare Card Coverage – Common Mechanisms of Drug Abuse and Obesity Some of the same brain mechanisms that fuel drug addiction in humans accompany the emergence of compulsive eating behaviors and the development of obesity in animals, according to research funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. ...
  8. Drug naming standard for electronic health records enhanced The RxNorm standard clinical drug vocabulary produced by the National Library of Medicine (NLM) now contains more accurate and complete connections between National Drug Codes (NDCs) and standard nonproprietary names of medications recommended for use in electronic health records (EHRs)....
  9. Apply Online for Extra Help with Medicare Prescription Drug Plan Costs Apply Online for Extra Help with Medicare Prescription Drug Plan Costs...
  10. Researchers design a light therapy that targets and destroys cancer cells in mice Researchers have designed a light-based therapy that allows the selective destruction of tumor cells in mice without harming surrounding normal tissue. This method of cancer therapy could theoretically work against tumors in humans, such as those of the breast, lung, prostate, as well as cancer cells in the blood such as leukemias, say scientists from […]...
  11. Investigational antiviral drug peramivir intravenous The U.S. Food and Drug Administration announced today that, in response to a request from the U.S. Centers for Disease Control and Prevention, it has issued an emergency use authorization (EUA) for the investigational antiviral drug peramivir intravenous (IV) in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are […]...
  12. How to Request a Replacement Medicare Card If You Recently Changed Your Address You told us you have moved and recently reported this to us. To ensure your privacy, you cannot request a replacement Medicare card online at this time. You must call or visit us to request a replacement card. To Contact Social Security: In the United States: Call our toll-free number 1-800-772-1213. If you are deaf […]...
  13. Information to Over 3 Million Disability Applicants Each Year – Medicare Card, Social Security to Provide Helpful Health Care Commissioner of Social Security, today announced the agency is providing helpful health care information and website links to the more than three million individuals who apply each year for Social Security and Supplemental Security Income (SSI) disability benefits. The website links take disability applicants to two U.S. Department of Health and Human Services (HHS) websites – www.healthfinder.gov where they will find information and tools to help them better understand and cope with their conditions; and www.healthfinder.gov/rxdrug where they may be able to get help paying for prescription drugs....
  14. Medicare card replacement, Verify U.S. Federal Government Social Media Accounts The government uses social media tools like Twitter, Facebook and YouTube to connect with people and communicate official information, so it’s important to know if a social media account is really managed by the federal government....
  15. Finding of long sought drug target structure may expedite drug discovery Researchers have solved the three-dimensional structure of a key biological receptor. The finding has the potential to speed drug discovery in many areas, from arthritis to respiratory disorders to wound healing, because it enables chemists to better examine and design molecules for use in experimental drugs....